A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular LymphomaA Phase 1b Dose Escalation/Expansion Study of Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesStudy of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Abeksinostat
@sh
Abeksinostat
@sr
Abexinostat
@es
abexinostat
@en
type
label
Abeksinostat
@sh
Abeksinostat
@sr
Abexinostat
@es
abexinostat
@en
altLabel
ABEXINOSTAT
@en
Abexinostat
@en
CRA-024781
@en
PCI-24781
@en
prefLabel
Abeksinostat
@sh
Abeksinostat
@sr
Abexinostat
@es
abexinostat
@en
P486
P592
P6366
P661
P662
P665
P683
P117
P2067
397.163771
P231
783355-60-2
P232
P233
CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO
P234
1S/C21H23N3O5/c1-24(2)13-17-16 ...... -13H2,1-2H3,(H,22,26)(H,23,25)
P235
MAUCONCHVWBMHK-UHFFFAOYSA-N
P2566
100.241.399
P274
C₂₁H₂₃N₃O₅
P3117
DTXSID30229005